Department: Pharmaceutical Sciences
University: Nova Southeastern University
Country: United States
Dr. Rizvi pursued his M.S and Ph.D. combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, Dr. Rizvi was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to the US and International patent). At Mercer, Dr. Rizvi was trained in the areas of Solid Dosage Formulations (directly compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, Dr. Rizvi was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization. Moreover, He pursued part-time postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. He has published many peer-reviewed articles in top ranking journals and two book chapters. Dr. Rizvi also presented his work through posters and oral presentations at national and international conferences.
His research interest, mainly focuses on Micro and Nano-Technology for Drug Delivery, Controlled Release Formulations, Solid State Chemistry of the Drugs, Surface Chemistry, Analytical Chemistry, Soft Material Chemistry, Forensic Chemistry, Organic Chemistry, Natural Product Chemistry, Vaccinology and Immunology.
Veterinary and Animal Medicine
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: firstname.lastname@example.org
Copyright © 2020 Boffin Access Limited.